Literature DB >> 6453999

Human postthymic precursor cells in health and disease. VII. Immunoregulatory circuits of the peripheral blood mononuclear cells from patients with progressive systemic sclerosis.

D Alarcón-Segovia, R Palacios, G Ibáñez de Kasep.   

Abstract

The study of T cell subpopulations and their immunoregulatory circuits in 9 patients with progressive systemic sclerosis (PSS) and 9 age/sex matched controls showed: 1. Normal postthymic precursor autologous rosette-forming T cells (Tar cells). 2. Normal T cells with receptors for the Fc portion of IgG(Ty). 3. Decreased T cells with receptor for Fc portion of IgM(Tmu). 4. Normal function of postthymic precursors. 5. Normal Concanavalin-A-induced and spontaneously-expanded suppressor cell functions. 6. Abnormally increased T helper cell function. These findings suggest that the primary immunoregulatory aberration in PSS is at the level of Tmu cells and their helper function. Relationship between this T cell disturbance and fibroblast function may explain the pathogenesis of PSS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6453999

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  9 in total

1.  Increase in activated T cells and reduction in suppressor inducer T cells in systemic sclerosis.

Authors:  R Gustafsson; T H Tötterman; L Klareskog; R Hällgren
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

2.  Mixed connective tissue disease: some statements.

Authors:  D Alarcón-Segovia
Journal:  Clin Rheumatol       Date:  1982-06       Impact factor: 2.980

3.  T-cell imbalance in progressive systemic sclerosis defined by monoclonal antibodies.

Authors:  A L Claudy; J C Le Petit; H Barthelemy; F Garcier
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

4.  Defective Epstein-Barr virus specific suppressor T cell function in progressive systemic sclerosis.

Authors:  A Kahan; A Kahan; C J Menkes; B Amor
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

5.  Differences in the kinetics of the autologous mixed lymphocyte reaction between the various connective tissue diseases.

Authors:  A Laffón; J Alcocer-Varela; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

6.  Natural killer cell-mediated activity in mixed connective tissue disease and its response to induction by interleukin-2.

Authors:  R González-Amaro; J Alcocer-Varela; E Martínez-Cordero; D Alarcón-Segovia
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

7.  Differences in the production of and/or the response to interleukin-2 by T lymphocytes from patients with the various connective tissue diseases.

Authors:  J Alcocer-Varela; A Laffón; D Alarcón-Segovia
Journal:  Rheumatol Int       Date:  1984       Impact factor: 2.631

8.  Spontaneous production of, and defective response to, interleukin-1 by peripheral blood mononuclear cells from patients with scleroderma.

Authors:  J Alcocer-Varela; E Martinez-Cordero; D Alarcon-Segovia
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

9.  T lymphocyte subset abnormalities and HLA antigens in scleroderma (systemic sclerosis).

Authors:  A J Barnett; B D Tait; M A Barnett; B H Toh
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.